Mitomycin and fluorouracil with concurrent radiation (FUMIR) regimen for anal cancer

Brittany N. White, James Waddell, Dominic A. Solimando

Research output: Contribution to journalReview article

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc, 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@aol.com; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net. 2013

Original languageEnglish (US)
Pages (from-to)464-469
Number of pages6
JournalHospital Pharmacy
Volume48
Issue number6
DOIs
StatePublished - Jun 1 2013

Fingerprint

Anus Neoplasms
Oncology
Postal Service
Mitomycin
Pharmacists
Fluorouracil
Radiation
Pharmaceutical Services
Chemotherapy
Poisons
Highway systems
Antineoplastic Agents
Drug Therapy
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Pharmacy

Cite this

Mitomycin and fluorouracil with concurrent radiation (FUMIR) regimen for anal cancer. / White, Brittany N.; Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 48, No. 6, 01.06.2013, p. 464-469.

Research output: Contribution to journalReview article

White, Brittany N. ; Waddell, James ; Solimando, Dominic A. / Mitomycin and fluorouracil with concurrent radiation (FUMIR) regimen for anal cancer. In: Hospital Pharmacy. 2013 ; Vol. 48, No. 6. pp. 464-469.
@article{c2f09047e2ac49fa8ab56a9adeacdf5f,
title = "Mitomycin and fluorouracil with concurrent radiation (FUMIR) regimen for anal cancer",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc, 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@aol.com; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net. 2013",
author = "White, {Brittany N.} and James Waddell and Solimando, {Dominic A.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1310/hpj4806-464",
language = "English (US)",
volume = "48",
pages = "464--469",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "6",

}

TY - JOUR

T1 - Mitomycin and fluorouracil with concurrent radiation (FUMIR) regimen for anal cancer

AU - White, Brittany N.

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc, 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@aol.com; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net. 2013

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc, 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@aol.com; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net. 2013

UR - http://www.scopus.com/inward/record.url?scp=84878610364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878610364&partnerID=8YFLogxK

U2 - 10.1310/hpj4806-464

DO - 10.1310/hpj4806-464

M3 - Review article

VL - 48

SP - 464

EP - 469

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 6

ER -